The Infinity-Lock was developed by Xiros, owner of the Neoligaments brand, in conjunction with leading orthopaedic surgeons Prof. Angus Wallace and Mr. Matthew Ravenscroft. Officially a Xiros product, the device is currently being distributed by Neoligaments, and is available alongside the existing Neoligaments product portfolio.
The Infinity-Lock is a permanent implantable device, comprising a specially-designed polyester Tube-Tape which loops securely around the coracoid, and an interference screw which offers high strength, low profile fixation.
The first Infinity-Lock procedure took place on 19th April 2016, and judging by the high volume of orders already received for this product, it looks set to be the first of many.
For further information, including IFU leaflets and ordering information, please visit https://www.neoligaments.com/product/infinity-lock/.